Filing
1st Quarter - Report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 21, 2025
Income
$60,000.00
What the client paid this registrant for the period.
Client based in
District of Columbia
Bills named in this filing
1
Lobbying activity
3
Healthcare policy issues as they relate to the pharmaceutical industry including drug pricing and biosimilars
Issues related to drug pricing, biosimilars, Medicare Part D and Medicare Part B; H.R. 3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021
Issues related to visas